MENU
ENSC
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Ensysce Biosciences (ENSC) Earnings Date & Reports
Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs... Show more
A.I. Advisor
published Earnings
ENSC is expected to report earnings to fall 5.00% to -18 cents per share on November 13
Q3'26
Est.
$-0.19
Q2'26
Beat
by $0.51
Q1'26
Beat
by $0.30
Q4'25
Beat
by $0.33
Q3'25
Missed
by $0.22
The last earnings report on August 19 showed earnings per share of -20 cents, beating the estimate of -70 cents. With 63.90K shares outstanding, the current market capitalization sits at 6.40M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Related Blogs
Interesting Articles
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Industry
N/A
Address
7946 Ivanhoe Avenue
Phone
+1 858 263-4196
Employees
10
Web
https://www.ensysce.com